Regulatory T cells control toxicity in a humanized model of IL-2 therapy
High dose IL-2 is a viable treatment option for cancer immune therapy, but the underlying mechanism for the accompanying undesirable morbidity is unclear. Here the authors show, using human immune system mouse models, that regulatory T cells and their functions on effector T cells are essential modu...
Main Authors: | Yan Li, Helene Strick-Marchand, Ai Ing Lim, Jiazi Ren, Guillemette Masse-Ranson, Dan Li, Gregory Jouvion, Lars Rogge, Sophie Lucas, Bin Li, James P. Di Santo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-01570-9 |
Similar Items
-
A novel mouse model for stable engraftment of a human immune system and human hepatocytes.
by: Helene Strick-Marchand, et al.
Published: (2015-01-01) -
Editorial: Role of the IL-23/IL-17 Pathway in Chronic Immune-Mediated Inflammatory Diseases: Mechanisms and Targeted Therapies
by: Elisabetta Bianchi, et al.
Published: (2021-09-01) -
Effects of IL-4 on regulatory T cells
by: Ying Yu Chen, et al.
Published: (2012) -
Overexpression and Selectively Regulatory Roles of IL-23/IL-17 Axis in the Lesions of Oral Lichen Planus
by: Rui Lu, et al.
Published: (2014-01-01) -
Neurons lacking iron regulatory protein-2 are highly resistant to the toxicity of hemoglobin
by: Raymond F. Regan, et al.
Published: (2008-08-01)